Ribosomal protein S27-like and S27 interplay with p53-MDM2 axis as a target, a substrate and a regulator

X Xiong1, Y Zhao, H He

  • 1Division of Radiation and Cancer Biology, Department of Radiation Oncology, University of Michigan, Ann Arbor, MI 48109, USA.

Oncogene
|December 21, 2010
PubMed

Insights

Ribosomal proteins RPS27L and RPS27 regulate the p53-MDM2 axis. RPS27L, a p53 target and MDM2 substrate, stabilizes p53 levels, impacting cell growth and stress responses.

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Cancer Research

Background:

  • Ribosomal proteins influence cellular processes, including tumor suppression.
  • The p53-MDM2 axis is a critical regulator of cell fate, with MDM2 targeting p53 for degradation.
  • RPS27L was previously identified as a p53-inducible gene, suggesting a role in the p53 pathway.

Purpose of the Study:

  • To investigate the regulatory roles of RPS27L and RPS27 in the p53-MDM2 interaction.
  • To elucidate the mechanisms by which RPS27L and RPS27 affect p53 stability and function.
  • To determine the functional consequences of RPS27L and RPS27 interaction with MDM2.

Main Methods:

  • Co-immunoprecipitation assays to assess protein-protein interactions.
  • Western blotting to analyze protein levels and half-lives.
  • siRNA-mediated gene silencing to evaluate functional impacts.
  • Subcellular localization studies using immunofluorescence.

Main Results:

  • RPS27L and RPS27 bind to MDM2, competing with p53 for binding and forming a triplex complex.
  • RPS27L is a short-lived MDM2 substrate, and its degradation is dependent on MDM2 domains.
  • Ectopic expression of RPS27L or RPS27 stabilizes p53 by inhibiting MDM2-mediated ubiquitination, while RPS27L silencing destabilizes p53.
  • RPS27L shuttles to the nucleus upon p53 activation and is crucial for maintaining both cytoplasmic and nuclear p53 levels.

Conclusions:

  • RPS27L and RPS27 are novel regulators of the p53-MDM2 axis.
  • RPS27L acts as a p53 target, an MDM2 substrate, and a crucial regulator of p53 stability and function.
  • The interplay between RPS27L/S27 and the p53-MDM2 pathway offers new insights into cancer biology and potential therapeutic strategies.

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
Covalently Linked Protein Regulators02:04

Covalently Linked Protein Regulators

Proteins can undergo many types of post-translational modifications, often in response to changes in their environment. These modifications play an important role in the function and stability of these proteins. Covalently linked molecules include functional groups, such as methyl, acetyl, and phosphate groups, and also small proteins, such as ubiquitin. There are around 200 different types of covalent regulators that have been identified.
These groups modify specific amino acids in a protein.
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...